These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 9988765)

  • 1. Activation of nuclear factor of activated T cells-(NFAT) and activating protein 1 (AP-1) by oncogenic 70Z Cbl requires an intact phosphotyrosine binding domain but not Crk(L) or p85 phosphatidylinositol 3-kinase association.
    van Leeuwen JE; Paik PK; Samelson LE
    J Biol Chem; 1999 Feb; 274(8):5153-62. PubMed ID: 9988765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The oncogenic 70Z Cbl mutation blocks the phosphotyrosine binding domain-dependent negative regulation of ZAP-70 by c-Cbl in Jurkat T cells.
    van Leeuwen JE; Paik PK; Samelson LE
    Mol Cell Biol; 1999 Oct; 19(10):6652-64. PubMed ID: 10490604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 70Z/3 Cbl induces PLC gamma 1 activation in T lymphocytes via an alternate Lat- and Slp-76-independent signaling mechanism.
    Graham LJ; Verí MC; DeBell KE; Noviello C; Rawat R; Jen S; Bonvini E; Rellahan B
    Oncogene; 2003 Apr; 22(16):2493-503. PubMed ID: 12717426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ras-dependent, Ca2+-stimulated activation of nuclear factor of activated T cells by a constitutively active Cbl mutant in T cells.
    Liu YC; Elly C; Langdon WY; Altman A
    J Biol Chem; 1997 Jan; 272(1):168-73. PubMed ID: 8995243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dual regulation of T cell receptor-mediated signaling by oncogenic Cbl mutant 70Z.
    Zhang Z; Elly C; Altman A; Liu YC
    J Biol Chem; 1999 Feb; 274(8):4883-9. PubMed ID: 9988730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effects of Cbl and 70Z/3 Cbl on T cell receptor-induced phospholipase Cgamma-1 activity.
    Graham LJ; DeBell KE; Verí M; Stoica B; Mostowski H; Bonvini E; Rellahan B
    FEBS Lett; 2000 Mar; 470(3):273-80. PubMed ID: 10745081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The linker phosphorylation site Tyr292 mediates the negative regulatory effect of Cbl on ZAP-70 in T cells.
    Rao N; Lupher ML; Ota S; Reedquist KA; Druker BJ; Band H
    J Immunol; 2000 May; 164(9):4616-26. PubMed ID: 10779765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The involvement of the proto-oncogene p120 c-Cbl and ZAP-70 in CD2-mediated T cell activation.
    Lin H; Martelli MP; Bierer BE
    Int Immunol; 2001 Jan; 13(1):13-22. PubMed ID: 11133830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The protein product of the c-cbl oncogene rapidly complexes with the EGF receptor and is tyrosine phosphorylated following EGF stimulation.
    Bowtell DD; Langdon WY
    Oncogene; 1995 Oct; 11(8):1561-7. PubMed ID: 7478580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancement of fcgamma receptor-mediated phagocytosis by transforming mutants of Cbl.
    Sato N; Kim MK; Schreiber AD
    J Immunol; 1999 Dec; 163(11):6123-31. PubMed ID: 10570302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A direct interaction between the adaptor protein Cbl-b and the kinase zap-70 induces a positive signal in T cells.
    Zhang Z; Elly C; Qiu L; Altman A; Liu YC
    Curr Biol; 1999 Feb; 9(4):203-6. PubMed ID: 10074432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of Epstein-Barr virus/C3d receptor (gp140, CR2, CD21) on human B lymphoma cell surface triggers Cbl tyrosine phosphorylation, its association with p85 subunit, Crk-L and Syk and its dissociation with Vav.
    Lottin-Divoux S; Jean D; Le Romancer M; Frade R
    Cell Signal; 2006 Aug; 18(8):1219-25. PubMed ID: 16289966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T cell activation induces direct binding of the Crk adapter protein to the regulatory subunit of phosphatidylinositol 3-kinase (p85) via a complex mechanism involving the Cbl protein.
    Gelkop S; Babichev Y; Isakov N
    J Biol Chem; 2001 Sep; 276(39):36174-82. PubMed ID: 11418612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Requirements for pYXXM motifs in Cbl for binding to the p85 subunit of phosphatidylinositol 3-kinase and Crk, and activation of atypical protein kinase C and glucose transport during insulin action in 3T3/L1 adipocytes.
    Standaert ML; Sajan MP; Miura A; Bandyopadhyay G; Farese RV
    Biochemistry; 2004 Dec; 43(49):15494-502. PubMed ID: 15581361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein kinase C activation inhibits tyrosine phosphorylation of Cbl and its recruitment of Src homology 2 domain-containing proteins.
    Liu Y; Liu YC; Meller N; Giampa L; Elly C; Doyle M; Altman A
    J Immunol; 1999 Jun; 162(12):7095-101. PubMed ID: 10358153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. v-Crk activates the phosphoinositide 3-kinase/AKT pathway by utilizing focal adhesion kinase and H-Ras.
    Akagi T; Murata K; Shishido T; Hanafusa H
    Mol Cell Biol; 2002 Oct; 22(20):7015-23. PubMed ID: 12242282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stimulation through the T cell receptor induces Cbl association with Crk proteins and the guanine nucleotide exchange protein C3G.
    Reedquist KA; Fukazawa T; Panchamoorthy G; Langdon WY; Shoelson SE; Druker BJ; Band H
    J Biol Chem; 1996 Apr; 271(14):8435-42. PubMed ID: 8626543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-2 stimulation induces tyrosine phosphorylation of p120-Cbl and CrkL and formation of multimolecular signaling complexes in T lymphocytes and natural killer cells.
    Gesbert F; Garbay C; Bertoglio J
    J Biol Chem; 1998 Feb; 273(7):3986-93. PubMed ID: 9461587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tyrosine kinase activity of the EGF receptor is enhanced by the expression of oncogenic 70Z-Cbl.
    Thien CB; Langdon WY
    Oncogene; 1997 Dec; 15(24):2909-19. PubMed ID: 9416834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential expression and signaling of CBL and CBL-B in BCR/ABL transformed cells.
    Sattler M; Pride YB; Quinnan LR; Verma S; Malouf NA; Husson H; Salgia R; Lipkowitz S; Griffin JD
    Oncogene; 2002 Feb; 21(9):1423-33. PubMed ID: 11857085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.